40
Participants
Start Date
February 23, 2023
Primary Completion Date
November 1, 2025
Study Completion Date
November 1, 2025
IBC-Ab002
An anti-PD-L1 monoclonal antibody
Placebo
Normal Saline
Barzilai Medical Center, Ashkelon
Rabin Medical Center, Petah Tikva
Sheba Medical Center, Ramat Gan
Tel-Aviv Sourasky Medical Center, Tel Aviv
Brain Research Center, Amsterdam
University Hospital Southampton NHS Foundation Trust, Southampton
Dementia Research Centre, National Hospital for Neurology and Neurosurgery, London
Sheffield teaching Hospitals NHS Trust, London
RICE - Research Institute for the Care of Older People, Bath
King's College London - Institute of Psychiatry, Psychology & Neuroscience (IoPPN), London
Lead Sponsor
National Institute on Aging (NIA)
NIH
Alzheimer's Association
OTHER
Immunobrain Checkpoint
INDUSTRY